{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:08:33Z","timestamp":1781518113681,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.humpath.2010.08.022","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T04:10:41Z","timestamp":1294114241000},"page":"833-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior"],"prefix":"10.1016","volume":"42","author":[{"given":"Belen","family":"Canet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2010.08.022_bb0005","series-title":"Pathology of the ovary","first-page":"153","article-title":"Clear cell tumors","author":"Prat","year":"2004"},{"key":"10.1016\/j.humpath.2010.08.022_bb0010","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","article-title":"Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma","volume":"99","author":"Itamochi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2010.08.022_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0898-6568(98)00063-1","article-title":"Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling","volume":"11","author":"Olofsson","year":"1999","journal-title":"Cell Signal"},{"key":"10.1016\/j.humpath.2010.08.022_bb0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tcb.2005.05.001","article-title":"GDIs: central regulatory molecules in Rho GTPase activation","volume":"15","author":"DerMardirossian","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","article-title":"Rho GTPases and the actin cytoskeleton","volume":"279","author":"Hall","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.humpath.2010.08.022_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-007-9119-1","article-title":"Rho GTPases: functions and association with cancer","volume":"24","author":"Ellenbroek","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.humpath.2010.08.022_bb0040","first-page":"5282","article-title":"Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma","volume":"9","author":"Shikada","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2010.08.022_bb0045","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2010.08.022_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004347-200104000-00004","article-title":"Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types","volume":"20","author":"Stern","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0075","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/1097-0142(197712)40:6<3019::AID-CNCR2820400639>3.0.CO;2-M","article-title":"Clear cell carcinoma of the ovary: light and electron microscopic studies","volume":"40","author":"Ohkawa","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.08.022_bb0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/01.LAB.0000073128.16098.31","article-title":"Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma","volume":"83","author":"Horiuchi","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2010.08.022_bb0085","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1349-7006.2008.00977.x","article-title":"Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with lovastatin may be useful for ovarian cancer","volume":"99","author":"Horiuchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2010.08.022_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1892","article-title":"p21-activated kinases in cancer","volume":"6","author":"Kumar","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2010.08.022_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.25005","article-title":"Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion","volume":"127","author":"Siu","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2010.08.022_bb0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)63458-X","article-title":"Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma","volume":"163","author":"Schraml","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nsmb.1533","article-title":"miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42","volume":"16","author":"Park","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ncb1875","article-title":"p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug","volume":"11","author":"Wang","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-642-59349-9_3","article-title":"Stromal cell involvement in cancer","volume":"162","author":"Almholt","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.humpath.2010.08.022_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2008.03.007","article-title":"Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression","volume":"18","author":"Bourguignon","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/modpathol.2010.75","article-title":"Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: manifestation of serial stromal remodeling","volume":"23","author":"Kato","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0140","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.08.022_bb0145","first-page":"281","article-title":"Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary","volume":"100","author":"Itamochi","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2010.08.022_bb0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1074\/mcp.M500140-MCP200","article-title":"Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels","volume":"5","author":"Stewart","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.humpath.2010.08.022_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4143\/crt.2005.37.4.251","article-title":"Characterization of RhoA-mediated chemoresistance in gastric cancer cells","volume":"37","author":"Kang","year":"2005","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.humpath.2010.08.022_bb0160","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1158\/1535-7163.MCT-06-0684","article-title":"Wnt3\/RhoA\/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism","volume":"6","author":"Kobune","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.humpath.2010.08.022_bb0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/0008-5472.540.65.2","article-title":"Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model","volume":"65","author":"Hashimoto","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2010.08.022_bb0170","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/cncr.20941","article-title":"Geranylgeranylacetone inhibits lysophosphatidic acid\u2013induced invasion of human ovarian carcinoma cells in vitro","volume":"103","author":"Hashimoto","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2010.08.022_bb0175","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ncb1795","article-title":"Scaffolding function of PAK in the PDK1-Akt pathway","volume":"10","author":"Higuchi","year":"2008","journal-title":"Nat Cell Biol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817710003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:32:38Z","timestamp":1758645158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817710003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0046817710003710"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2010.08.022","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2010.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}